Attributing the costs of health & social care Research & Development Understanding AcoRD
|
|
- Corey Walters
- 8 years ago
- Views:
Transcription
1 Attributing the costs of health & social care Research & Development Understanding AcoRD Trudi Simmons Senior Manager Research Finance & Programmes 1
2 Implementation Intoduction Basic principles behind the guidance The attribution process Common problems in attributing costs 2
3 Implementation AcoRD Published in May 2012 & adopted by England, Scotland, Wales & NI Published on the Gov at: 1. Working Group established to look at key issues around implementation 3
4 Principles of AcoRD Based on original principles set out in HSG(97)32 Uses the same three cost categories and definitions as HSG(97)32 Focuses on why an activity takes place rather than where or by whom Focuses on the Primary Purpose of an activity 4
5 Three sections Format of Guidance Main section that covers the background, principles and attribution process Annex A provides an Exemplar list of activities and where they should be attributed Annex B provides a set of Frequently Asked Questions (FAQs) updated regularly 5
6 Exemplar Lists Split into 3 sections Research, Support and Treatment Research Section has 2 parts Part A costs met by all grant funders Part B costs met by grant funders except where the funder is a member of the AMRC when DH will meet the cost. 6
7 The Categories of Costs Three types of costs: Research costs Treatment costs NHS Service Support Costs 7
8 Research Costs Costs of the R&D itself that end when the research ends. They relate to activities that are being undertaken to answer the research questions Met by grant funders through the award of a research grant except for PART B costs if funder is an AMRC member DH will meet PART B costs mainly via Research Capability funding (RCF) and Networks 8
9 Treatment Costs Patient care costs which would continue to be incurred if the patient care service in question continued to be provided after the R&D study had stopped 1. For the purposes of the attribution it should be assumed that an experimental intervention/ service being tested will continue after the end of the study Met through the normal commissioning process 9
10 Excess Treatment Costs (ETCs) ETCs are the difference between the cost of usual care and the cost of the treatment provided as part of the study Sometimes there are treatment savings rather than excess treatment costs 10
11 NHS Service Support Costs The additional patient care costs associated with the research, which would end once the R&D activity in question had stopped, even if the patient care involved continued to be provided Met from the R&D budget by the Health Departments of the United Kingdom 11
12 Attribution Process Concept of NHS patient care services and the premise that the NHS bears the cost of caring for its patients even when they are involved in a research study NHS patient care service is defined as a service provided by, or on behalf of, the NHS where that service treats, or contributes to, the care needs of a patient. 12
13 Two step approach step 1 Identify the core R&D activities the are being undertaken to answer the research question and which end when the research ends. These activities do not contribute to a NHS patient care service. These are Research Costs Examples of Research Costs are contained in Annex A 13
14 Step 2 NHS Patient Care Service Activities Activity that is part of NHS Services must be split between: NHS Treatment Costs NHS Support Costs 14
15 Treatment or Support Activity An activity is a NHS Treatment activity If it is integral to the provision of a treatment regime, whether this is standard or experimental An activity is a NHS Service Support activity if the patient care activity is primarily undertaken to facilitate research or is driven by the NHS duty of care to a patient, eg to ensure the safety of a patient participating in research 15
16 The attribution process Step 1 Step 2 In the context of this study is the activity a service provided by, or on behalf of, the NHS where that service treats or contributes to the care needs of a patient Yes No The activity is a patient care cost. Is the activity integral to the provision of a treatment (or diagnostic) regime? The activity is a Research Cost because it is not directly contributing to patient care Is the funder an AMRC member? Yes The activity is a Treatment Cost No The activity is a Service Support Cost Attribute Research activities between Part A and Part B 16
17 Treatment Costs As a rule of thumb most interventions that are being tested or compared as part of a study will be treatment costs even if they are experimental, unlicensed for the condition, not NICE approved, or there are no plans to continue with the intervention after the study has ended because the CCGs won t fund But placebo or sham treatments are research costs 17
18 Examples of NHS Support Activities The processing of the patient record to identify patients who may be suitable to approach to ask if they wish to participate in a research project; Obtaining informed consent; Additional investigations, assessments and tests where the results are required by the patient s care team to ensure patient safety and where arrangements are in place to feed the results back to the clinician 18
19 19 Common issues Attributing the costs of R&D is complex DH piloting an Activity Capture and Attribution Template (ACAT) to help No one size fits all Need to understand the detail of the study Why is the activity taking place? What usually happens to a patient? What would happen to the patient if they had the same treatment outside of a research study? Network support applies to research taking place in the NHS or in a NHS service provider Efficient study design can help to minimise cost Seek appropriate advice before grant submission
20 Common attribution mistakes Not referring back to the definitions of the 3 types of costs Attributing treatment costs as Support or Research costs Assuming because an activity takes place in the NHS it must be a NHS cost not true Assuming that funding for NHS Support and Treatment costs works in the same way as funding for research costs 20
21 21 NHS SSC Case Study Pam Gurney, University of Exeter Medical School
22 University of Exeter Medical School Case Study 1. Brief history of the School 2. Details on the funder 3. How we dealt with the difficult terms and conditions
23 Brief History of the University of Exeter Medical School 2002 took our first students as Peninsula Medical School (PMS) 2007 became the Peninsula College of Medicine and Dentistry (PCMD) 2013 split from Plymouth University and became the University of Exeter Medical School (UEMS)
24 Funder An AMRC Registered Charity As an AMRC registered charity, will not be required to pay (detailed in AcoRD Appendix A, Part B) are as follows: o Local study trial co-ordination and management. o Data collection needed to answer the questions that the research study is addressing (including collecting data for and completing the report). o Regulatory preparation and compliance including obtaining ethical approval and complying with the Medicine for Human Use (Clinical Trials) Regulations o The time taken by Chief and Principal Investigators (CI and PI) to explain the study to professional colleagues, and to understand, the research elements of a study. For example the time taken to explain the criteria for patient eligibility or to explain the randomisation protocol. o Sponsorship fees such as MHRA fees, and CTA annual renewal fees.
25 Our Solution United front with the academic / clinician One meeting the attendees being the academic, the HEI representative and the CRN representative Open discussion between all parties Contact with the CRN to make them aware of the cost commitment should the bid go ahead
26 Conclusion It is necessary, when dealing with SSC and ETCs that we work together with both the academic and the CRN to ensure that things are costed correctly. We understand the rules of each individual funder to ensure that we can attribute these costs appropriately.
Attributing the costs of health and social care Research & Development (AcoRD)
Frequently Asked Questions Annex B Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS Support Costs
More informationAttributing the costs of Health and Social Care Research & Development (AcoRD)
HSC R&D Division Attributing the costs of Health and Social Care Research & Development (AcoRD) Contents Contents... 2 Purpose... 3 Background... 3 Basic Principles...4 Commercial Contract Studies...4-5
More informationAttributing the costs of health and social care Research and Development (AcoRD)
Frequently Asked Questions Annex B - Scotland Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS
More informationThe people needed to complete the costs for a funding application are:
Research Design Service London Guide to costing grant applications The people needed to complete the costs for a funding application are: The chief investigators and or senior researchers Your local Trust,
More informationAttributing the costs of health and social care Research and Development (AcoRD)
Attributing the costs of health and social care Research and Development (AcoRD) Page 1 of 8 Contents Contents. 2 Purpose.. 3 Background. 3 Basic Principles.. 4 Commercial Contract Studies.. 4 Non-commercial
More informationResearch funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro
Research funding applications involving Cardiff & Vale UHB Emma Lewis R&D Coordinator Objectives R&D review of grant applications Identifying resources required for your project Attributing costs using
More informationQ1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS?
Annex B Frequently Asked Questions Updated May 2015 Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs,
More informationAttributing the costs of health and social care Research & Development (AcoRD)
Frequently Asked Questions Updated December 2015 Annex B Contents 1. Introduction... 2 2. Funding sources... 2 3. Clinical Research Network funding... 5 4. Application advice services/nhs permissions...
More informationSummary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
More informationAn introduction to Research Management and Governance (RM&G) in the NHS
An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,
More informationStudy-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review
UK STUDY-WIDE GOVERNANCE CRITERIA FOR R&D REVIEW INTRODUCTION The following document is intended to provide operational guidance to the person taking the UK lead in conducting the R&D Study-Wide review
More informationPROPOSED REVISED GUIDANCE TO NHS BOARDS FOR CONSULTATION
Dear Colleague Arrangements for NHS Patients Receiving Private Healthcare 1. This letter provides revised guidance to NHS Boards covering situations where patients obtain private healthcare in addition
More informationROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
More informationCRN: South London Funding Model
Summary of Partnership Group Agreement to Clinical Research Network: South London Funding Model Proposal 1. Introduction The Clinical Research Network: South London (CRN: South London) was formed in April
More informationCommissioning Policy: Implementation and funding of NICE guidance. April 2013. Reference : NHSCB/CP/05
Commissioning Policy: Implementation and funding of NICE guidance April 2013 Reference : NHSCB/CP/05 NHS Commissioning Board Commissioning Policy: Implementation and funding of guidance produced by the
More informationManaging Research in Hospices
Managing Research in Hospices Paul Perkins Consultant in Palliative Medicine Gloucestershire Hospitals NHS Foundation Trust and Sue Ryder Leckhampton Court Hospice Cheltenham Why? We need to know what
More informationForm PG4 Developmental Research Project Grant Guidance for Applicants
Form PG4 Developmental Research Project Grant Guidance for Applicants Research Department, Stroke Association, Stroke Association House, 240 City Road, London EC1V 2PR, Tel: 0207 566 1543 Email: research@stroke.org.uk
More informationTRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
More informationNational Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in
More informationDoes my project require review by a Research Ethics Committee?
National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project
More informationEU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
More informationArchiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
More informationRESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group
RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS Reference No: UHB 074 Version No: 5 Previous Trust / LHB Ref No: N/A Documents to read alongside
More informationCLINICAL RESEARCH NETWORK
CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
More informationBy e-mail. To Attached List. 12 December 2008. Dear Colleague. Arrangements for NHS Patients Receiving Private Healthcare
Healthcare Policy and Strategy Directorate Derek Feeley, Director T: 0131-244 1727 F: 0131-244 2042 E: derek.feeley@scotland.gsi.gov.uk By e-mail To Attached List 12 December 2008 Dear Colleague Arrangements
More informationWales Patient Access Scheme: Process Guidance
Wales Patient Access Scheme: Process Guidance July 2012 (Updated September 2014) This guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics
More informationCommissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare
Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare Although Primary Care Trusts (PCTs) and East Midlands Specialised Commissioning Group (EMSCG) were abolished
More informationResearch is everybody s business
Research and Development Strategy (DRAFT) 2013-2018 Research is everybody s business 1 Information Reader Box to be inserted for documents six pages and over. (To be inserted in final version, after consultation
More informationDocument Title: Research Database Application (ReDA)
Document Title: Research Database Application (ReDA) Document Number: SOP035 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationgsop-32-02 - Vendor Assessment SOP page 1 of 10
gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development
More informationResearch Study Close-down and Archiving Procedures
Title: Outcome Statement: Research Study Close-down and Archiving Procedures To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationUncontrolled When Printed. Version 1.1. Consultation Group: Approver: Co-ordinators: Grampian Medicines Management Group. Deputy Director of Pharmacy
NHS Grampian Staff Policy For Patients To Receive Aspects Of Their Treatment Through Private Healthcare Providers (Co-Payments) In Respect Of Medicines Co-ordinators: Deputy Director of Pharmacy Consultation
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders
STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2
More informationResearch Governance Framework for Health and Social Care
Research Governance Framework for Health and Social Care Second edition, 2005 Research Governance Framework for Health and Social Care Foreword The Research Governance Framework outlines principles of
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Undertaking Risk Assessment of a Research and Development Project SOP Number: 33 Version Number: 1.0 Supercedes: N/A Effective
More informationPERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS
PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIALS DATA RECORD ADJUSTMENT PROCESS Version Control Amended small error in Acronyms table (page 2) 1 Acronyms CTP FPR MHRA REC SOP TMB VRA Clinical
More informationThe Practicalities of Data Standards
The Practicalities of Data Standards Provided by Catherine Carpenter-Clawson, Research Network Manager For EDGE User Conference 2014 17 th March 2014 Contents Example 1: Local challenges with study arm
More informationSTANDARD OPERATING PROCEDURE. Risk Assessment of STH sponsored CTIMPs
Research Department STANDARD OPERATING PROCEDURE of STH sponsored CTIMPs SOP History None SOP Number C118 Created STH Research Department (EW) Reviewed STH Research Department (EW) Superseded Version 1.0,
More informationCONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
More informationAppendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007
Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT POLICY AND PROCESS FOR DECISION MAKING September 2007 Approved by Board: 6 th September 2007 Date Implemented: 1 st October 2007 Review Date: September 2008
More informationA Guide to Clinical Trials
A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.
More informationCOMMERCIAL SPONSORSHIP ETHICAL STANDARDS FOR THE NHS
November 2000 DEPT OF HEALTH LOGO COMMERCIAL SPONSORSHIP ETHICAL STANDARDS FOR THE NHS Contact point and queries Any queries on this document should, in the first instance, be directed to the Regional
More informationGP Patient Survey Your doctor, your experience, your say
GP Patient Survey Your doctor, your experience, your say Guidance 2007/08 for strategic health authorities, primary care trusts and GP practices Introduction 1. This document provides guidance on this
More informationGuidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1)
Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) What is the HRA Statement of Activities? The Statement of Activities is part of the application
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY Policy Title Version: Approved by: Date of approval: 29 June 2015 Policy supersedes: Lead Board Director: Policy Lead (and author if different): Name of responsible committee/group:
More informationEuropean cross border healthcare: Information for commissioners
European cross border healthcare: Information for commissioners Published: June 2014 1 2 European Cross Border Healthcare Information for Commissioners First published: July 2013 Updated: June 2014 3 Contents
More informationNHS Chartutes - A Guide to the governing Body
Constitutional Changes Proposed by Legal Advisers At Clause 4.1.2, changed the term Board to Governing Body to align with the term used in the legislation. Page 14. Amended Clause 4.8.1 to clarify the
More informationResearch governance policy
Research governance policy Responsible Officer Author Ben Bennett, Business Planning & Resources Director Sarah Garner, Associate Director, Science Policy & Research Programme Date effective from July
More informationConsultancy spending approval process: Initial guidance to NHS foundation trusts
Annex One Consultancy spending approval process: Initial guidance to NHS foundation trusts Summary 1. Monitor, the NHS Trust Development Authority (TDA) and NHS England are jointly implementing an approval
More informationOVERVIEW OF IPTR AND NON-FORMULARY PROCESS IN THE ACUTE SECTOR
5.2: POLICY FOR THE MANAGEMENT OF INDIVIDUAL PATIENT TREATMENT REQUESTS IMPORTANT NOTE: This policy document is subject to review pending the introduction of the Peer Approval Clinical System which will
More informationMRC. Clinical Trials. Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS. Medical Research Council
MRC Clinical Trials Series MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 Medical Research Council MRC GUIDELINES FOR GOOD CLINICAL PRACTICE IN CLINICAL TRIALS 1998 MRC GUIDELINES FOR
More informationResearch Governance Framework for Health and Social Care in Wales Second Edition
Research Governance Framework for Health and Social Care in Wales Second Edition Contents Foreword 1 1. Purpose and Scope 3 2. Standards 7 2.1 Introduction 7 2.2 Ethics 8 2.3 Science 13 2.4 Information
More informationEX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH
EX GRATIA PROVISION OF XYREM TO PANDEMRIX AND NARCOLEPSY PERSONAL INJURY CLAIMANTS BY THE DEPARTMENT OF HEALTH Introduction 1. This note describes the Department of Health s (DH) ex gratia and time-limited
More informationResponding to the NHS Constitution
December 2012 Developing the AMRC response to the consultation on the NHS Constitution The government is updating the NHS Constitution so that it will better reflect the legal rights and responsibilities
More informationSutton & Merton Clinical Commissioning Groups Charitable Funds Grant Application Form. Background, Policy and Criteria for the award of grants
Sutton & Merton Clinical Commissioning Groups Charitable Funds Grant Application Form Background, Policy and Criteria for the award of grants Sutton and Merton Clinical Commissioning Groups Charitable
More informationResearch in the NHS HR Good Practice Resource Pack
Research in the NHS HR Good Practice Resource Pack Acknowledgements The Research Passport system was first developed in Greater Manchester by a partnership of NHS organisations and the University of Manchester.
More informationRevision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
More informationGP Patient Survey Your Doctor, Your Experience, Your Say
To: GP Practices Chief Executives of Primary Care Trusts Dear Colleague GP Patient Survey Your Doctor, Your Experience, Your Say This letter confirms arrangements for delivery of the 2008 GP Patient Survey.
More informationIn April 2010, changes to both the GMS and PMS regulations came into force which:
GPC GUIDANCE: USE OF 084 NUMBERS BY GP PRACTICES Revised June 2012 (first edition published July 2011) Introduction A number of GP practices use telephone systems with non-geographical numbers, such as
More informationSection 5 onwards provides information aimed at researchers who are interested in working with us.
NORWICH CLINICAL TRIALS UNIT This document provides an overview of the Norwich Clinical Trials Unit: Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure for our stakeholders and
More informationDESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Page 1 of 17 TABLE OF CONTENTS INTRODUCTION 4 EXECUTIVE SUMMARY 4 PUBLIC HEALTH BENEFITS 5 Good clinical practice 5 Good manufacturing
More informationANNEX 11: ASSET MANAGEMENT POLICY
ANNEX 11: ASSET MANAGEMENT POLICY Electricity North West Limited Registered Office: 304 Bridgewater Place, Birchwood Park, Warrington, Cheshire. WA3 6XG. Registered no: 2366949 (England) Electricity North
More informationA Guide to Pharmacy Documentation For Clinical Trials
A Guide to Pharmacy Documentation For Clinical Trials Roy Sinclair Clinical Trials Pharmacist St. George s Hospital (to Sep 2007) Lecturer Kingston University January 2008 A Guide to Pharmacy Documentation
More informationImplementing the Research Governance Framework Guidelines for New Researchers. Juliet MacArthur Alison Goulbourne
Implementing the Research Governance Framework Guidelines for New Researchers Juliet MacArthur Alison Goulbourne March 2007 0 Note from the authors This document is designed to provide a step by step guide
More informationResponsibilities for meeting Patient Care Costs associated with Research and Development in the NHS
Health Service Guidelines - ExEcut#m HsG(97)32 29 May 1997 Responsibilities for meeting Patient Care Costs associated with Research and Development in the NHS Executive summary Part J - General Responsibilities
More informationLegal and governance framework
Annex A Legal and governance framework This annex is a brief guide to the legal and governance framework relevant to research in the UK. It is not intended to be a comprehensive statement of the law or
More informationPreparing an effective bid
Vascular Risk Assessment (Vascular Checks) - a new Local Enhanced Service Part 2 Preparing an effective bid Version 1.1 Guidance prepared by PSNC to support Local Pharmaceutical Committees About this guidance
More informationTrust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer
Trust/Host Site Approval Presented by: Anika Kadchha Research Governance Officer Joint Research & Enterprise Office Training 19 th January Outline What is Research NHS Ethics (if required) Host Site Approval
More informationIntroduction 2. 1. The Role of Pharmacy Within a NHS Trust 3. 2. Pharmacy Staff 4. 3. Pharmacy Facilities 5. 4. Pharmacy and Resources 6
Index Index Section Page Introduction 2 1. The Role of Pharmacy Within a NHS Trust 3 2. Pharmacy Staff 4 3. Pharmacy Facilities 5 4. Pharmacy and Resources 6 5. Prescription Charges 7 6. Communication
More informationDocument Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability
Document Title: Supply of Clinical Trials Investigational Material: Document Number: SOP072 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G
More informationProcess for advising on the feasibility of implementing a patient access scheme
Process for advising on the feasibility of implementing a patient access scheme INTERIM September 2009 Patient Access Schemes Liaison Unit at NICE P001_PASLU_Process_Guide_V1.3 Page 1 of 21 Contents (to
More informationSpecialty Selection Test (SST) Pilot INFORMATION PACK
Specialty Selection Test (SST) Pilot INFORMATION PACK Page 1 of 18 Contents Section 1: Introduction... 2 Section 2: One-page overview... 2 Section 3: FAQs for Applicants... 3 Section 2: FAQs for LETBs/Deaneries/Specialties...
More informationChemicals and Life Sciences Industry Practice. Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom
Chemicals and Life Sciences Industry Practice Insurance and compensation in the event of injury in Phase I clinical trials in the United Kingdom i Insurance and compensation in the event of injury in Phase
More informationStandard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
More informationPolicy Research Programme Summary Final Report Form
Policy Research Programme Summary Final Report Form 1. Project Details Project Title: Project Duration: (months) Evaluation of the costs and benefits of computerised on-scene decision support for ambulance
More informationPUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION
PUBLIC HEALTH WALES NHS TRUST CHIEF EXECUTIVE JOB DESCRIPTION Post Title: Accountable to: Chief Executive and Accountable Officer for Public Health Wales NHS Trust Trust Chairman and Board for the management
More informationPUBLIC HEALTH LIMITED OPEN CALL SCHEME (LOCS) PHA202 RESEARCH BRIEFING
Introduction PUBLIC HEALTH LIMITED OPEN CALL SCHEME (LOCS) PHA202 RESEARCH BRIEFING Following publication of its new national health research strategy Best Research for Best Health (DH 2006a), the Department
More informationINFORMATION GOVERNANCE REVIEW EVIDENCE GATHERING: COMMISSIONING
INFORMATION GOVERNANCE REVIEW EVIDENCE GATHERING: COMMISSIONING Introduction In producing these questions, the Information Governance Review Panel has reviewed the legal and statutory basis for the processing
More informationInformatics: The future. An organisational summary
Informatics: The future An organisational summary DH INFORMATION READER BOX Policy HR/Workforce Management Planning/Performance Clinical Document Purpose Commissioner Development Provider Development Improvement
More informationNORWICH CLINICAL TRIALS UNIT OVERVIEW
NORWICH CLINICAL TRIALS UNIT OVERVIEW This document provides an overview of the Norwich Clinical Trials Unit. Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure. Section 4 gives
More informationAppropriate staffing in health and care settings
NMC Briefing Appropriate staffing in health and care settings What is the NMC s interest in staffing? The importance of appropriate staffing was reinforced by the Francis Reports into failings at Mid Staffordshire
More informationInformation Governance Strategy. Version No 2.0
Plymouth Community Healthcare CIC Information Governance Strategy Version No 2.0 Notice to staff using a paper copy of this guidance. The policies and procedures page of PCH Intranet holds the most recent
More informationNHS North Durham Clinical Commissioning Group. Information Governance Strategy 2015/16
NHS North Durham Clinical Commissioning Group Information Governance Strategy 2015/16 Document Status Equality Impact Assessment Document Ratified/Approved By Final No impact Risk and Audit Committee/Governing
More informationGuidance on nominating a consultee for research involving adults who lack capacity to consent
Guidance on nominating a consultee for research involving adults who lack capacity to consent Issued by the Secretary of State and the Welsh Ministers in accordance with section 32(3) of the Mental Capacity
More informationIHEEM WORKING WITH YOU TO DEVELOP YOUR CAREER
TO DEVELOP www.iheem.org.uk Joint letter by President and CEO Joint letter by President and CEO Shaping the healthcare engineering and estate management landscape The Institute of Healthcare Engineering
More information1 Introduction... 1. 2 History... 2. 3 Employing authority/trust indemnity: who is covered for what?... 3
This guidance note describes the NHS indemnity scheme introduced in January 1990 and alerts members to its limitations. Members are advised to retain defence body membership or take out personal indemnity
More informationInformation Governance Policy
Information Governance Policy Version: 4 Bodies consulted: Caldicott Guardian, IM&T Directors Approved by: MT Date Approved: 27/10/2015 Lead Manager: Governance Manager Responsible Director: SIRO Date
More informationThe anatomy of a grant proposal
The anatomy of a grant proposal 1 st October 2015 / Lucy Parker, MaryCate MacLennan, Steff Hazlehurst Excellence in specialist and community healthcare The anatomy of a grant proposal 1st October 2015
More informationThis document explains the main differences between two sets of performance metrics:
Document Version 2.0 Date November 2013 The (70 day benchmark) and the NIHR Clinical Research Network High Level Objectives: a description of purpose, definition and differences Introduction This document
More informationSpecification Document (11/1023)
Responsive funding in the NIHR SDO programme: open call (with special interest in studies with an economic/costing component) Closing date 1.00pm on 15 September 2011 1. Introduction This is the fifth
More informationEvaluating the ENAT : reconciling findings from a mixed methods study
School of Healthcare FACULTY OF MEDICINE AND HEALTH Evaluating the ENAT : reconciling findings from a mixed methods study Professor Claire A Hale School of Healthcare University of Leeds On behalf of the
More informationMedical Device Alert. Device Peristeen anal irrigation system manufactured by Coloplast Limited. Action by
Medical Device Alert Issued: 26 February 2014 at 16:00 Device Peristeen anal irrigation system manufactured by Coloplast Limited. Problem Risk of using transanal irrigation inappropriately. The manufacturer
More information2.1 The NIHR Faculty Version 7 (July 2015) THE NIHR FACULTY
THE NIHR FACULTY Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the NIHR Faculty
More informationThe Research Design Service Yorkshire and the Humber CONTENTS TOP TIPS FOR QUALITATIVE RESEARCH TOP TIPS FOR QUANTITATIVE PROPOSALS
The Research Design Service Yorkshire and the Humber CONTENTS TOP TIPS FOR QUALITATIVE RESEARCH TOP TIPS FOR QUANTITATIVE PROPOSALS TOP TIPS FOR SYSTEMATIC REVIEWS TOP TIPS FOR ECONOMIC EVALUATION TOP
More informationNew medicines in Scotland
NHS SCOTLAND New medicines in Scotland who decides what the NHS can provide? What is this factsheet about? This factsheet explains the process that medicines go through before NHS doctors in Scotland can
More informationWe are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands.
The Prep handbook We are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands. We exist to safeguard the health and wellbeing of the public. We set standards
More informationWHAT ARE THE SPECIFIC DIFFERENCES BETWEEN VERSION 5.5 AND VERSION 5.6 OF THE RESEARCH ETHICS COMMITTEE STANDARD APPLICATION FORM?
Application Form Cover Sheet - Addition of Application Version No. in Version 5.6 - Addition of Application Date in Version 5.6 - Remove Principal Investigator (deletion) - Remove Applicant s Signature
More informationManaging Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey
Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how
More informationInformation for members
Information for members I-04-63 Suggested distribution Vice-Chancellors and Principals, Pro Vice- Chancellors (Research), University Registrars and Secretaries, Directors of Human Resources, Deans/Heads
More informationSystematic Reviews. knowledge to support evidence-informed health and social care
Systematic Reviews knowledge to support evidence-informed health and social care By removing uncertainties in science and research, systematic reviews ensure that only the most effective and best-value
More information